| Lastest Insider Transactions Of NovoCure Ltd ( NVCR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NVCR | NovoCure Ltd | Leonard Frank X | Chief Executive Officer | 2026-06-04 | Sell | 34,273 | 17.93 | 614,635 | 2026-06-05 16:28:00 |
| NVCR | NovoCure Ltd | VERNON W ANTHONY | Directior | 2026-06-02 | Sell | 2,945 | 15.77 | 46,445 | 2026-06-03 16:52:48 |
| NVCR | NovoCure Ltd | VERNON W ANTHONY | Directior | 2026-04-28 | Option Exercise | 21,500 | 11.39 | 244,885 | 2026-04-28 16:27:46 |
| NVCR | NovoCure Ltd | Leupin Nicolas | Former Chief Medical Officer | 2026-03-04 | Sell | 1,100 | 13.31 | 14,636 | 2026-03-05 16:33:41 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chf Medical and Innovation Ofr | 2026-03-03 | Sell | 6,412 | 13.31 | 85,314 | 2026-03-05 16:32:22 |
| NVCR | NovoCure Ltd | Brackmann Christoph | Chief Financial Officer | 2026-03-03 | Sell | 6,412 | 13.31 | 85,314 | 2026-03-05 16:31:55 |
| NVCR | NovoCure Ltd | Leonard Frank X | Chief Executive Officer | 2026-03-03 | Sell | 5,607 | 13.31 | 74,603 | 2026-03-05 16:31:35 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2026-03-03 | Sell | 48,623 | 13.72 | 667,214 | 2026-03-05 16:31:19 |
| NVCR | NovoCure Ltd | Puri Michal Nath | Chief Human Resources Officer | 2026-03-03 | Sell | 1,100 | 13.31 | 14,636 | 2026-03-05 16:31:04 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chf Medical and Innovation Ofr | 2026-02-27 | Sell | 10,733 | 13.68 | 146,863 | 2026-03-03 16:11:29 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Executive Officer | 2025-09-05 | Buy | 81,550 | 12.22 | 996,859 | 2025-09-08 07:10:52 |
| NVCR | NovoCure Ltd | Brackmann Christoph | Chief Financial Officer | 2025-07-29 | Buy | 20,000 | 11.59 | 231,800 | 2025-07-30 16:33:06 |
| NVCR | NovoCure Ltd | Stafford Kristin | Directior | 2025-06-03 | Sell | 999 | 17.28 | 17,259 | 2025-06-04 16:26:18 |
| NVCR | NovoCure Ltd | LEUNG GABRIEL | Directior | 2025-06-03 | Sell | 999 | 17.31 | 17,297 | 2025-06-04 16:24:53 |
| NVCR | NovoCure Ltd | Madden Martin J. | Directior | 2025-06-03 | Sell | 999 | 17.19 | 17,176 | 2025-06-04 16:23:47 |
| NVCR | NovoCure Ltd | Scannell Timothy J | Directior | 2025-06-03 | Sell | 999 | 17.32 | 17,299 | 2025-06-04 16:22:19 |
| NVCR | NovoCure Ltd | HILLEMAN JERYL L | Directior | 2025-06-03 | Sell | 999 | 17.26 | 17,247 | 2025-06-04 16:17:28 |
| NVCR | NovoCure Ltd | Ocean Allyson J | Directior | 2025-06-03 | Sell | 999 | 17.29 | 17,269 | 2025-06-04 16:16:06 |
| NVCR | NovoCure Ltd | VERNON W ANTHONY | Directior | 2025-06-03 | Sell | 999 | 17.35 | 17,329 | 2025-06-04 16:14:26 |
| NVCR | NovoCure Ltd | Hung David | Directior | 2025-06-03 | Sell | 999 | 17.30 | 17,280 | 2025-06-04 16:11:57 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-06-02 | Sell | 30,196 | 17.50 | 528,413 | 2025-06-04 16:09:33 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2025-05-03 | Sell | 592 | 17.91 | 10,604 | 2025-05-05 16:17:51 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | 2025-03-03 | Sell | 268 | 18.92 | 5,071 | 2025-03-04 16:19:23 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-03-03 | Sell | 2,527 | 18.54 | 46,841 | 2025-03-04 16:19:12 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Executive Officer | 2025-03-03 | Sell | 2,053 | 18.54 | 38,055 | 2025-03-04 16:19:00 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | 2025-03-03 | Sell | 4,637 | 18.75 | 86,949 | 2025-03-03 21:27:07 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sell | 13,494 | 19.72 | 266,126 | 2025-03-03 21:26:48 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sell | 15,036 | 19.70 | 296,257 | 2025-03-03 21:26:33 |
| NVCR | NovoCure Ltd | Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sell | 1,387 | 20.02 | 27,773 | 2025-03-03 21:26:23 |
| NVCR | NovoCure Ltd | Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sell | 991 | 20.02 | 19,844 | 2025-03-03 21:26:14 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sell | 2,014 | 19.71 | 39,688 | 2025-03-03 21:26:06 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | 2025-02-28 | Sell | 4,637 | 18.75 | 86,949 | 2025-03-03 16:28:29 |
| NVCR | NovoCure Ltd | Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sell | 991 | 20.02 | 19,844 | 2025-03-03 16:28:11 |
| NVCR | NovoCure Ltd | Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sell | 1,387 | 20.02 | 27,773 | 2025-03-03 16:27:51 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sell | 15,036 | 19.70 | 296,257 | 2025-03-03 16:27:32 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sell | 13,494 | 19.72 | 266,126 | 2025-03-03 16:26:55 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sell | 2,014 | 19.71 | 39,688 | 2025-03-03 16:26:03 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2025-01-11 | Sell | 2,160 | 26.81 | 57,906 | 2025-01-15 16:23:58 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2024-11-02 | Sell | 44 | 16.69 | 734 | 2024-11-06 16:27:08 |
| NVCR | NovoCure Ltd | Puri Michal Nath | Chief Human Resources Officer | 2024-10-31 | Sell | 810 | 15.79 | 12,792 | 2024-11-04 16:34:52 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-11-01 | Sell | 598 | 15.94 | 9,531 | 2024-11-04 16:34:12 |
| NVCR | NovoCure Ltd | Paravasthu Mukund | Chief Operating Officer | 2024-11-01 | Sell | 160 | 15.88 | 2,540 | 2024-11-04 16:32:28 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-06-05 | Option Exercise | 124,373 | 22.82 | 2,838,192 | 2024-06-07 16:06:56 |
| NVCR | NovoCure Ltd | VERNON W ANTHONY | Directior | 2024-06-04 | Sell | 964 | 23.89 | 23,033 | 2024-06-06 17:43:03 |
| NVCR | NovoCure Ltd | Scannell Timothy J | Directior | 2024-06-04 | Sell | 964 | 23.89 | 23,027 | 2024-06-06 17:42:42 |
| NVCR | NovoCure Ltd | LEUNG GABRIEL | Directior | 2024-06-04 | Sell | 964 | 23.89 | 23,025 | 2024-06-06 17:42:19 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-03-01 | Sell | 2,519 | 16.02 | 40,358 | 2024-03-05 16:08:02 |
| NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-02-27 | Sell | 2,078 | 16.14 | 33,545 | 2024-02-29 16:38:56 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-02-27 | Sell | 2,303 | 16.14 | 37,177 | 2024-02-29 16:28:11 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-11-07 | Sell | 382 | 12.65 | 4,832 | 2023-11-08 16:22:37 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-10-31 | Option Exercise | 17,968 | 9.60 | 172,453 | 2023-11-02 16:20:51 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-09-01 | Sell | 883 | 21.82 | 19,265 | 2023-09-05 16:24:39 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-09-01 | Sell | 294 | 21.82 | 6,414 | 2023-09-05 16:24:18 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-09-01 | Sell | 273 | 21.82 | 5,956 | 2023-09-05 16:23:32 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-08-02 | Sell | 1,144 | 30.25 | 34,607 | 2023-08-04 16:02:21 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-03 | Sell | 13,609 | 75.55 | 1,028,165 | 2023-03-07 16:52:16 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-03-03 | Sell | 21,421 | 76.16 | 1,631,411 | 2023-03-07 16:52:00 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-03 | Sell | 25,635 | 76.16 | 1,952,346 | 2023-03-07 16:51:48 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-03-03 | Sell | 5,505 | 76.16 | 419,258 | 2023-03-07 16:51:15 |
| NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-03-03 | Sell | 593 | 76.16 | 45,163 | 2023-03-07 16:50:35 |
| NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-03-02 | Sell | 281 | 75.28 | 21,153 | 2023-03-06 16:42:42 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-03-02 | Sell | 937 | 75.28 | 70,535 | 2023-03-06 16:41:07 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-02 | Sell | 1,213 | 75.28 | 91,312 | 2023-03-06 16:40:52 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-03-02 | Sell | 1,055 | 75.28 | 79,418 | 2023-03-06 16:40:12 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sell | 2,903 | 76.95 | 223,393 | 2023-03-06 16:37:48 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sell | 4,107 | 75.38 | 309,578 | 2023-03-03 16:13:03 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-02-28 | Sell | 1,684 | 76.36 | 128,594 | 2023-03-02 17:01:17 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-02-28 | Sell | 1,923 | 76.36 | 146,845 | 2023-03-02 17:00:09 |
| NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-02-28 | Sell | 2,198 | 76.36 | 167,845 | 2023-03-02 16:55:26 |
| NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-02-28 | Sell | 755 | 76.36 | 57,654 | 2023-03-02 16:51:19 |
| NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-02-28 | Sell | 2,164 | 76.36 | 165,248 | 2023-03-02 16:49:32 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Officer | 2023-01-05 | Sell | 8,143 | 116.14 | 945,756 | 2023-01-09 18:24:06 |
| NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Officer | 2023-01-05 | Option Exercise | 1,946 | 47.04 | 91,540 | 2023-01-09 18:24:06 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sell | 39,507 | 112.25 | 4,434,654 | 2023-01-09 18:21:59 |
| NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Option Exercise | 35,209 | 15.39 | 541,697 | 2023-01-09 18:21:59 |
| NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | 2023-01-05 | Sell | 387 | 108.00 | 41,796 | 2023-01-09 18:20:06 |
| NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sell | 212,500 | 108.74 | 23,106,230 | 2023-01-09 18:18:44 |
| NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | 2023-01-05 | Option Exercise | 212,500 | 7.66 | 1,627,125 | 2023-01-09 18:18:44 |